Literature DB >> 29151092

Conversion, Factitious Disorder and Malingering: A Distinct Pattern or a Continuum?

Silvio Galli, Laurent Tatu, Julien Bogousslavsky, Selma Aybek.   

Abstract

This chapter is aimed at highlighting the recent findings concerning physiopathology, diagnosis, and management of conversion, factitious disorder, and malingering. Conversion disorder is the unintentional production of neurological symptom, whereas malingering and factitious disorder represent the voluntary production of symptoms with internal or external incentives. They have a close history and this has been frequently confounded. Practitioners are often confronted to medically unexplained symptoms; they represent almost 30% of neurologist's consultation. The first challenge is to detect them, and recent studies have confirmed the importance of "positive" clinical bedside signs based on incoherence and discordance, such as the Hoover's sign for the diagnosis of conversion disorder. Functional neuroimaging has allowed a better understanding of the pathophysiology, and highlighted abnormal cerebral activation patterns in conversion disorder in relation to motor, emotional, and limbic networks, different from feigners. This supports the theory evoked by Charcot of a "psychodynamic lesion," which is also reflected by the new term introduced in the DSM-5: functional neurological disorder. Multidisciplinary therapy is recommended with behavioral cognitive therapy, antidepressant to treat frequent comorbid anxiety or depression, and physiotherapy. Factitious disorder and malingering should be clearly delineated from conversion disorder. Factitious disorder should be considered as a mental illness and more research on its physiopathology and treatment is needed, when malingering is a non-medical condition encountered in medico-legal cases.
© 2018 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2017        PMID: 29151092     DOI: 10.1159/000475699

Source DB:  PubMed          Journal:  Front Neurol Neurosci        ISSN: 0300-5186


  8 in total

1.  Medico-legal aspects of functional neurological disorders: time for an interdisciplinary dialogue.

Authors:  Michela Colombari; Ilaria A Di Vico; Stefania Turrina; Domenico De Leo; Michele Tinazzi
Journal:  Neurol Sci       Date:  2021-04-03       Impact factor: 3.307

2.  The Development of a Short Chinese Version of the State-Trait Anxiety Inventory.

Authors:  Qingyun Du; Haowen Liu; Chengjiao Yang; Xiaoyu Chen; Xiaoyuan Zhang
Journal:  Front Psychiatry       Date:  2022-05-09       Impact factor: 5.435

Review 3.  Factitious Disorders in Everyday Clinical Practice.

Authors:  Constanze Hausteiner-Wiehle; Sven Hungerer
Journal:  Dtsch Arztebl Int       Date:  2020-06-26       Impact factor: 5.594

Review 4.  Decade of progress in motor functional neurological disorder: continuing the momentum.

Authors:  David L Perez; Mark J Edwards; Glenn Nielsen; Kasia Kozlowska; Mark Hallett; W Curt LaFrance
Journal:  J Neurol Neurosurg Psychiatry       Date:  2021-03-15       Impact factor: 13.654

5.  Modification of both functional neurological symptoms and neuroimaging patterns with a good anatomoclinical concordance: a case report.

Authors:  Silvio Galli; Selma Aybek; Sylvie Chokron; Thierry Moulin; Eloi Magnin
Journal:  BMC Neurol       Date:  2019-11-04       Impact factor: 2.474

6.  A descriptive, retrospective case series of patients with factitious disorder imposed on self.

Authors:  Antoine Bérar; Guillaume Bouzillé; Patrick Jego; Jean-Sébastien Allain
Journal:  BMC Psychiatry       Date:  2021-11-23       Impact factor: 3.630

Review 7.  Functional neurological disorders in personal injury.

Authors:  Wendy Phillips
Journal:  BMJ Neurol Open       Date:  2021-03-12

Review 8.  The factitious/malingering continuum and its burden on public health costs: a review and experience in an Italian neurology setting.

Authors:  Marco Onofrj; Anna Digiovanni; Paola Ajdinaj; Mirella Russo; Claudia Carrarini; Massimo Di Giannantonio; Giovanni Martinotti; Stefano L Sensi
Journal:  Neurol Sci       Date:  2021-08-04       Impact factor: 3.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.